Free Trial

Aptevo Therapeutics (APVO) Competitors

Aptevo Therapeutics logo
$4.38 -0.08 (-1.79%)
Closing price 01/31/2025 04:00 PM Eastern
Extended Trading
$4.37 -0.01 (-0.21%)
As of 01/31/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

APVO vs. ADXN, HOTH, BLRX, BFRI, RDHL, OBSV, CYCN, ORGS, EVAX, and ABVC

Should you be buying Aptevo Therapeutics stock or one of its competitors? The main competitors of Aptevo Therapeutics include Addex Therapeutics (ADXN), Hoth Therapeutics (HOTH), BioLineRx (BLRX), Biofrontera (BFRI), RedHill Biopharma (RDHL), ObsEva (OBSV), Cyclerion Therapeutics (CYCN), Orgenesis (ORGS), Evaxion Biotech A/S (EVAX), and ABVC BioPharma (ABVC). These companies are all part of the "pharmaceutical products" industry.

Aptevo Therapeutics vs.

Aptevo Therapeutics (NASDAQ:APVO) and Addex Therapeutics (NASDAQ:ADXN) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, profitability, valuation, institutional ownership, analyst recommendations, earnings, community ranking, risk and dividends.

Addex Therapeutics has a net margin of 850.30% compared to Aptevo Therapeutics' net margin of 0.00%. Addex Therapeutics' return on equity of -112.43% beat Aptevo Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Aptevo TherapeuticsN/A -353.04% -132.42%
Addex Therapeutics 850.30%-112.43%-77.95%

Addex Therapeutics has lower revenue, but higher earnings than Aptevo Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aptevo Therapeutics$3.11M0.72-$17.41MN/AN/A
Addex Therapeutics$1.83M4.46-$11.76M-$0.34-22.65

Aptevo Therapeutics has a beta of 5.11, suggesting that its stock price is 411% more volatile than the S&P 500. Comparatively, Addex Therapeutics has a beta of 1.76, suggesting that its stock price is 76% more volatile than the S&P 500.

Aptevo Therapeutics received 184 more outperform votes than Addex Therapeutics when rated by MarketBeat users. However, 51.72% of users gave Addex Therapeutics an outperform vote while only 50.13% of users gave Aptevo Therapeutics an outperform vote.

CompanyUnderperformOutperform
Aptevo TherapeuticsOutperform Votes
199
50.13%
Underperform Votes
198
49.87%
Addex TherapeuticsOutperform Votes
15
51.72%
Underperform Votes
14
48.28%

Aptevo Therapeutics currently has a consensus target price of $10,952.00, indicating a potential upside of 249,945.66%. Addex Therapeutics has a consensus target price of $30.00, indicating a potential upside of 289.61%. Given Aptevo Therapeutics' higher possible upside, equities research analysts clearly believe Aptevo Therapeutics is more favorable than Addex Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aptevo Therapeutics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Addex Therapeutics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Aptevo Therapeutics had 3 more articles in the media than Addex Therapeutics. MarketBeat recorded 4 mentions for Aptevo Therapeutics and 1 mentions for Addex Therapeutics. Addex Therapeutics' average media sentiment score of 1.89 beat Aptevo Therapeutics' score of 0.47 indicating that Addex Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
Aptevo Therapeutics Neutral
Addex Therapeutics Very Positive

8.1% of Aptevo Therapeutics shares are owned by institutional investors. Comparatively, 16.1% of Addex Therapeutics shares are owned by institutional investors. 0.1% of Aptevo Therapeutics shares are owned by company insiders. Comparatively, 15.0% of Addex Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Addex Therapeutics beats Aptevo Therapeutics on 9 of the 14 factors compared between the two stocks.

Get Aptevo Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for APVO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

APVO vs. The Competition

MetricAptevo TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$2.23M$6.86B$5.56B$9.11B
Dividend YieldN/A2.90%5.31%3.98%
P/E RatioN/A9.9789.9918.25
Price / Sales0.72227.221,221.9274.93
Price / CashN/A73.5045.9637.70
Price / Book0.005.275.124.71
Net Income-$17.41M$136.98M$111.09M$224.24M
7 Day Performance-7.20%-0.62%2.38%1.08%
1 Month Performance1.62%0.15%3.20%1.51%
1 Year Performance-99.95%7.68%24.70%20.44%

Aptevo Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
APVO
Aptevo Therapeutics
2.5396 of 5 stars
$4.38
-1.8%
$10,952.00
+249,945.7%
-100.0%$2.23M$3.11M0.0050Short Interest ↓
ADXN
Addex Therapeutics
3.0523 of 5 stars
$8.53
+0.7%
$30.00
+251.7%
-29.0%$9.04M$1.83M-25.0930
HOTH
Hoth Therapeutics
2.699 of 5 stars
$1.22
-10.3%
$4.00
+227.9%
-8.7%$8.42MN/A-0.924Short Interest ↑
Gap Down
BLRX
BioLineRx
2.124 of 5 stars
$0.11
-3.9%
$9.00
+8,471.4%
-92.5%$8.39M$4.80M-0.4840Short Interest ↑
News Coverage
Gap Down
BFRI
Biofrontera
2.5738 of 5 stars
$1.04
-4.6%
$7.00
+573.1%
-15.0%$8.06M$34.07M-0.4670Short Interest ↓
RDHL
RedHill Biopharma
0.6601 of 5 stars
$6.23
-3.3%
N/A-98.4%$7.97M$6.53M0.00210Analyst Forecast
Short Interest ↑
News Coverage
Gap Up
OBSV
ObsEva
N/AN/AN/AN/A$7.94M$20.11M-0.1150Gap Up
CYCN
Cyclerion Therapeutics
2.6884 of 5 stars
$2.71
+1.1%
N/A+30.7%$7.34M$1.62M0.0030Positive News
Gap Up
ORGS
Orgenesis
N/A$1.52
+3.4%
N/AN/A$7.30M$530,000.000.00150News Coverage
EVAX
Evaxion Biotech A/S
2.9145 of 5 stars
$6.00
-0.5%
$55.00
+816.7%
-87.5%$7.02M$70,000.00-4.1460Short Interest ↓
News Coverage
Gap Down
ABVC
ABVC BioPharma
1.4234 of 5 stars
$0.54
+2.9%
N/A-66.0%$7.00M$150,000.00-0.6330Short Interest ↓
News Coverage

Related Companies and Tools


This page (NASDAQ:APVO) was last updated on 2/1/2025 by MarketBeat.com Staff
From Our Partners